Cargando…
Rac GTPases in Hematological Malignancies
Emerging evidence suggests that crosstalk between hematologic tumor cells and the tumor microenvironment contributes to leukemia and lymphoma cell migration, survival, and proliferation. The supportive tumor cell-microenvironment interactions and the resulting cellular processes require adaptations...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321480/ https://www.ncbi.nlm.nih.gov/pubmed/30558116 http://dx.doi.org/10.3390/ijms19124041 |
_version_ | 1783385452611371008 |
---|---|
author | Durand-Onaylı, Valerie Haslauer, Theresa Härzschel, Andrea Hartmann, Tanja Nicole |
author_facet | Durand-Onaylı, Valerie Haslauer, Theresa Härzschel, Andrea Hartmann, Tanja Nicole |
author_sort | Durand-Onaylı, Valerie |
collection | PubMed |
description | Emerging evidence suggests that crosstalk between hematologic tumor cells and the tumor microenvironment contributes to leukemia and lymphoma cell migration, survival, and proliferation. The supportive tumor cell-microenvironment interactions and the resulting cellular processes require adaptations and modulations of the cytoskeleton. The Rac subfamily of the Rho family GTPases includes key regulators of the cytoskeleton, with essential functions in both normal and transformed leukocytes. Rac proteins function downstream of receptor tyrosine kinases, chemokine receptors, and integrins, orchestrating a multitude of signals arising from the microenvironment. As such, it is not surprising that deregulation of Rac expression and activation plays a role in the development and progression of hematological malignancies. In this review, we will give an overview of the specific contribution of the deregulation of Rac GTPases in hematologic malignancies. |
format | Online Article Text |
id | pubmed-6321480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63214802019-01-07 Rac GTPases in Hematological Malignancies Durand-Onaylı, Valerie Haslauer, Theresa Härzschel, Andrea Hartmann, Tanja Nicole Int J Mol Sci Review Emerging evidence suggests that crosstalk between hematologic tumor cells and the tumor microenvironment contributes to leukemia and lymphoma cell migration, survival, and proliferation. The supportive tumor cell-microenvironment interactions and the resulting cellular processes require adaptations and modulations of the cytoskeleton. The Rac subfamily of the Rho family GTPases includes key regulators of the cytoskeleton, with essential functions in both normal and transformed leukocytes. Rac proteins function downstream of receptor tyrosine kinases, chemokine receptors, and integrins, orchestrating a multitude of signals arising from the microenvironment. As such, it is not surprising that deregulation of Rac expression and activation plays a role in the development and progression of hematological malignancies. In this review, we will give an overview of the specific contribution of the deregulation of Rac GTPases in hematologic malignancies. MDPI 2018-12-14 /pmc/articles/PMC6321480/ /pubmed/30558116 http://dx.doi.org/10.3390/ijms19124041 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Durand-Onaylı, Valerie Haslauer, Theresa Härzschel, Andrea Hartmann, Tanja Nicole Rac GTPases in Hematological Malignancies |
title | Rac GTPases in Hematological Malignancies |
title_full | Rac GTPases in Hematological Malignancies |
title_fullStr | Rac GTPases in Hematological Malignancies |
title_full_unstemmed | Rac GTPases in Hematological Malignancies |
title_short | Rac GTPases in Hematological Malignancies |
title_sort | rac gtpases in hematological malignancies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321480/ https://www.ncbi.nlm.nih.gov/pubmed/30558116 http://dx.doi.org/10.3390/ijms19124041 |
work_keys_str_mv | AT durandonaylıvalerie racgtpasesinhematologicalmalignancies AT haslauertheresa racgtpasesinhematologicalmalignancies AT harzschelandrea racgtpasesinhematologicalmalignancies AT hartmanntanjanicole racgtpasesinhematologicalmalignancies |